Mizuho analyst Salim Syed joins Analyst Thursdays to talk about this week’s news from Cytokinetics, Gilead, and more

blonca9
Jan 25, 2024
1 min read

Salim Syed discusses this morning’s FOREST-HCM update, Gilead’s Trodelvy news, CRISPR’s allo CAR-T pivot, BridgeBio’s possible reaction to HELIOS-B, and Vaxcyte’s pneumococcal vaccine readout coming up later this year.

Recent Posts

See All

Jones Research analyst Catherine Novack discusses Capricor's regulatory roller coaster, RNA editing, and more

Discussing hot button issues for biotech, and how they do or don't affect the mechanics of M&A, with one of the most experienced bankers in healthcare, Jefferies' Philip Ross

William Blair biotech analyst Andy Hsieh takes stock of the obesity space after attending the 2025 American Diabetes Association's (ADA's) 85th Scientific Sessions in Chicago

Mizuho analyst Salim Syed joins Analyst Thursdays to talk about this week’s news from Cytokinetics, Gilead, and more

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight